US Bancorp
LLY icon

US Bancorp’s Eli Lilly LLY Stock Holding History

US Bancorp’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25B Sell
1,357,610
-12,519
-0.9% -$12.7M 1.52% 13
2025
Q4 		$1.47B Sell
1,370,129
-3,919
-0.3% -$3.75M 1.73% 11
2025
Q3 		$1.05B Buy
1,374,048
+1,942
+0.1% +$1.45M 1.24% 15
2025
Q2 		$1.07B Sell
1,372,106
-61,987
-4% -$48.2M 1.35% 15
2025
Q1 		$1.18B Sell
1,434,093
-659,878
-32% -$549M 1.58% 10
2024
Q4 		$1.62B Sell
2,093,971
-88,598
-4% -$73.4M 2.12% 9
2024
Q3 		$1.93B Buy
2,182,569
+26,323
+1% +$23.7M 2.48% 8
2024
Q2 		$1.95B Buy
2,156,246
+29,631
+1% +$23.7M 2.66% 8
2024
Q1 		$1.65B Sell
2,126,615
-34,244
-2% -$24.4M 2.31% 9
2023
Q4 		$1.26B Sell
2,160,859
-136,331
-6% -$79.6M 1.86% 9
2023
Q3 		$1.22B Buy
2,297,190
+6,690
+0.3% +$3.45M 2% 9
2023
Q2 		$1.07B Sell
2,290,500
-16,016
-0.7% -$6.72M 1.73% 10
2023
Q1 		$792M Sell
2,306,516
-10,734
-0.5% -$3.62M 1.34% 12
2022
Q4 		$848M Buy
2,317,250
+168,522
+8% +$59.8M 1.5% 10
2022
Q3 		$695M Sell
2,148,728
-14,566
-0.7% -$4.62M 1.43% 10
2022
Q2 		$701M Buy
2,163,294
+484
+0% +$145K 1.36% 10
2022
Q1 		$619M Buy
2,162,810
+3,596
+0.2% +$925K 1.03% 15
2021
Q4 		$596M Sell
2,159,214
-4,387
-0.2% -$1.11M 0.94% 19
2021
Q3 		$500M Sell
2,163,601
-2,303
-0.1% -$568K 0.94% 22
2021
Q2 		$497M Buy
2,165,904
+1,457
+0.1% +$293K 0.93% 23
2021
Q1 		$404M Buy
2,164,447
+1,060
+0% +$207K 0.82% 24
2020
Q4 		$365M Sell
2,163,387
-3,797
-0.2% -$567K 0.79% 26
2020
Q3 		$321M Buy
2,167,184
+2,871
+0.1% +$444K 0.78% 27
2020
Q2 		$355M Sell
2,164,313
-3,437
-0.2% -$528K 0.93% 19
2020
Q1 		$301M Buy
2,167,750
+5,571
+0.3% +$765K 0.94% 22
2019
Q4 		$284M Sell
2,162,179
-2,860
-0.1% -$332K 0.73% 29
2019
Q3 		$242M Sell
2,165,039
-12,073
-0.6% -$1.34M 0.66% 37
2019
Q2 		$241M Sell
2,177,112
-91,299
-4% -$10.8M 0.67% 34
2019
Q1 		$294M Sell
2,268,411
-24,264
-1% -$2.95M 0.85% 25
2018
Q4 		$265M Sell
2,292,675
-1,201
-0.1% -$134K 0.86% 25
2018
Q3 		$246M Sell
2,293,876
-30,210
-1% -$3.02M 0.71% 27
2018
Q2 		$198M Buy
2,324,086
+4,789
+0.2% +$393K 0.61% 36
2018
Q1 		$179M Buy
2,319,297
+7,471
+0.3% +$601K 0.55% 42
2017
Q4 		$195M Sell
2,311,826
-23,881
-1% -$2.03M 0.6% 39
2017
Q3 		$200M Sell
2,335,707
-2,726
-0.1% -$224K 0.64% 35
2017
Q2 		$192M Buy
2,338,433
+1,146
+0% +$93.5K 0.64% 32
2017
Q1 		$197M Sell
2,337,287
-5,734
-0.2% -$459K 0.67% 27
2016
Q4 		$172M Sell
2,343,021
-20,170
-0.9% -$1.5M 0.62% 32
2016
Q3 		$190M Sell
2,363,191
-30,155
-1% -$2.41M 0.7% 28
2016
Q2 		$188M Sell
2,393,346
-4,605
-0.2% -$347K 0.72% 26
2016
Q1 		$173M Sell
2,397,951
-423
-0% -$32K 0.68% 28
2015
Q4 		$202M Sell
2,398,374
-7,682
-0.3% -$637K 0.81% 20
2015
Q3 		$201M Buy
2,406,056
+3,554
+0.1% +$300K 0.84% 22
2015
Q2 		$201M Sell
2,402,502
-4,622
-0.2% -$352K 0.78% 22
2015
Q1 		$175M Buy
2,407,124
+14,926
+0.6% +$1.06M 0.67% 30
2014
Q4 		$165M Buy
2,392,198
+2,836
+0.1% +$191K 0.64% 32
2014
Q3 		$155M Sell
2,389,362
-35,259
-1% -$2.23M 0.63% 37
2014
Q2 		$151M Buy
2,424,621
+21,880
+0.9% +$1.31M 0.6% 39
2014
Q1 		$141M Sell
2,402,741
-4,689
-0.2% -$262K 0.58% 40
2013
Q4 		$123M Buy
2,407,430
+613,326
+34% +$30.7M 0.5% 47
2013
Q3 		$90.3M Buy
1,794,104
+1,586
+0.1% +$83K 0.4% 54
2013
Q2 		$88M Buy
+1,792,518
New +$97.5M 0.4% 55

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

US Bancorp's LLY Position: Q1 2026 in Review

US Bancorp reduced its Eli Lilly (LLY) stake by 0.91% in Q1 2026, selling an estimated $12.7M and leaving 1,357,610 shares worth $1.25B. The position accounts for 1.52% of the portfolio, ranked #13.

US Bancorp first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.95B in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • US Bancorp held 1,357,610 shares of Eli Lilly worth $1.25B as of Q1 2026.
  • US Bancorp sold 12,519 Eli Lilly shares in Q1 2026, an estimated $12.7M.
  • Eli Lilly made up 1.52% of US Bancorp's portfolio in Q1 2026, its #13 holding.
  • US Bancorp first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • US Bancorp's Eli Lilly position peaked at $1.95B in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.